Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Forbion European Acquisition Corp Cl A (FRBN)

Forbion European Acquisition Corp Cl A (FRBN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 343,063
  • Shares Outstanding, K 15,813
  • Annual Sales, $ 0 K
  • Annual Income, $ 31 K
  • 60-Month Beta 0.00
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade FRBN with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.25 +134.54%
on 10/20/23
47.17 -54.01%
on 10/26/23
+10.73 (+97.95%)
since 09/29/23
3-Month
9.25 +134.54%
on 10/20/23
47.17 -54.01%
on 10/26/23
+10.90 (+101.07%)
since 07/28/23
52-Week
9.25 +134.54%
on 10/20/23
47.17 -54.01%
on 10/26/23
+11.55 (+113.74%)
since 10/28/22

Most Recent Stories

More News
enGene (Nasdaq: ENGN) Launched as Publicly Traded Genetic Medicines Company

/CNW/ - enGene Holdings Inc. ("enGene" or the "Company,") (NASDAQ: ENGN) today announced the completion of the previously announced business combination...

FRBN : 21.70 (-3.88%)
enGene Appoints Richard Bryce, MBChB, MRCGP, MFPM, as Chief Medical Officer

/PRNewswire/ - enGene, Inc., a clinical-stage biotechnology company mainstreaming gene therapy through its novel platform for the delivery of therapeutics to...

FRBN : 21.70 (-3.88%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 28.85
2nd Resistance Point 25.54
1st Resistance Point 23.62
Last Price 21.70
1st Support Level 18.39
2nd Support Level 15.08
3rd Support Level 13.16

See More

52-Week High 47.17
Fibonacci 61.8% 32.68
Fibonacci 50% 28.21
Fibonacci 38.2% 23.74
Last Price 21.70
52-Week Low 9.25

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar